...
首页> 外文期刊>Case Reports & Clinical Practice Review >Bone Marrow Mononuclear Cells Transplantation in Treatment of Established Bronchopulmonary Dysplasia: A Case Report
【24h】

Bone Marrow Mononuclear Cells Transplantation in Treatment of Established Bronchopulmonary Dysplasia: A Case Report

机译:骨髓单个核细胞移植治疗已确立的支气管肺发育不良:一例报告

获取原文
           

摘要

Objective: Management of emergency carBackground: Bronchopulmonary dysplasia (BDP) is an incurable disease. This study reports the successful treatment of a 30-week-old neonate with established bronchopulmonary dysplasia by bone marrow mononuclear cells (BM MNCs) transplantation. Case Report: The preterm infant with BPD requiring continuous oxygen administration for 4 months post-delivery under- went BM MNCs. Bone marrow was obtained from the patient’s iliac crests and mononuclear cells were isolated by density gradient centrifugation method. BM MNCs were delivered via endotracheal and intravenous routes. After BM MNCs transplantation, remarkable improvements were observed in oxygen saturation and lung CT as the infant was gradually weaned off oxygen supply. Conclusions: BM MNCs transplantation offers promising treatment of BPD.
机译:目的:急救车的管理背景:支气管肺发育不良(BDP)是一种不可治愈的疾病。这项研究报告了通过骨髓单核细胞(BM MNC)移植成功治疗了30周已确立的支气管肺发育不良的新生儿。病例报告:分娩后4个月需要连续供氧的BPD早产儿接受了BM MNC治疗。从患者的获得骨髓,并通过密度梯度离心法分离单个核细胞。 BM MNC通过气管内和静脉内途径递送。 BM MNCs移植后,随着婴儿逐渐断奶供氧,氧饱和度和肺部CT观察到明显改善。结论:BM MNCs移植为BPD提供了有希望的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号